Bottom line
HGHAX vs RYHIX: the short answer
HGHAX (The Hartford Healthcare Fund) and RYHIX (Health Care Fund) are both mutual funds.
HGHAX is cheaper at 1.33% vs 1.38% — a difference of $5.00 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
HGHAX vs RYHIX side by side
| HGHAX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Hartford | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.33% | 1.38% |
| Annual cost per $10k | $133 | $138 |
| 10-yr cost on $10k (prospectus) | $2,063 | $1,709 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | — | +14.4% |
| 5-yr return (annualized) | — | +5.1% |
| 10-yr return (annualized) | — | +7.9% |
| Best quarter | +20.9% | +18.7% |
| Worst quarter | −15.7% | −14.4% |
| Net assets (fund) | $772.2M | $19.4M |
| Number of holdings | 80 | 135 |
| Portfolio turnover | 49% | 244% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HGHAX | RYHIX | Difference |
|---|---|---|---|
| 2025 | +15.6% | +14.4% | +1.2% |
| 2024 | 0.0% | +0.6% | −0.6% |
| 2023 | +3.8% | +5.8% | −2.1% |
| 2022 | −11.7% | −11.6% | −0.1% |
| 2021 | +10.0% | +19.2% | −9.3% |
| 2020 | +22.6% | +18.9% | +3.6% |
| 2019 | +33.3% | +22.8% | +10.5% |
| 2018 | −3.0% | +1.6% | −4.6% |
| 2017 | +21.6% | +23.5% | −1.9% |
| 2016 | −8.6% | −9.4% | +0.8% |
Source: Fund prospectus bar charts
Holdings overlap
18 of HGHAX's top 25 holdings also appear in RYHIX's top 25.
| Holding | HGHAX | RYHIX |
|---|---|---|
| Eli Lilly & Co | 12.03% | 3.63% |
| Johnson & Johnson | 6.75% | 2.88% |
| Merck & Co Inc | 6.00% | 2.04% |
| UnitedHealth Group Inc | 4.74% | 2.22% |
| AbbVie Inc | 4.21% | 2.52% |
| Elevance Health Inc | 3.00% | 1.02% |
| Intuitive Surgical Inc | 2.88% | 1.31% |
| CVS Health Corp | 2.84% | 1.31% |
| Vertex Pharmaceuticals Inc | 2.64% | 1.34% |
| Danaher Corp | 2.57% | 1.30% |
| Edwards Lifesciences Corp | 2.48% | 0.84% |
| Regeneron Pharmaceuticals Inc | 2.02% | 0.90% |
| HCA Healthcare Inc | 1.88% | 0.87% |
| Boston Scientific Corp | 1.88% | 0.86% |
| Abbott Laboratories | 1.82% | 1.42% |
Source: SEC Form N-PORT
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between HGHAX and RYHIX?
Which is cheaper, HGHAX or RYHIX?
Should I own both HGHAX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.